Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality

Updated on: December 25,2023

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality

Updated on:December 25,2023

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with

Updated on: December 22,2023

Improving emotional well-being, quality of sleep, and decision making in patients at risk for breast cancer

byTel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University has determined that use of the Inquiry Based Stress Reduction (IBSR) technique among women with

Updated on:December 22,2023

Video animation guide to help young people living with cancer-related fatigue

byUniversity of BathCredit: University of BathA new resource has been launched by a team of psychologists at the University of Bath aiming to help young people living with cancer-related fatigue

Updated on: January 04,2024

Video animation guide to help young people living with cancer-related fatigue

byUniversity of BathCredit: University of BathA new resource has been launched by a team of psychologists at the University of Bath aiming to help young people living with cancer-related fatigue

Updated on:January 04,2024

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on: January 26,2024

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on:January 26,2024

New insight into protein could pave the way for new cancer treatments

FEBRUARY 29, 2024by Anna Björklund, Identification of a conformational switch in c-MYC.aOverview of the MD strategy employed to identify regions that exhibit probe-induced conformational changes

Updated on: March 15,2024

New insight into protein could pave the way for new cancer treatments

FEBRUARY 29, 2024by Anna Björklund, Identification of a conformational switch in c-MYC.aOverview of the MD strategy employed to identify regions that exhibit probe-induced conformational changes

Updated on:March 15,2024

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on: January 22,2024

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on:January 22,2024

Oral sex is now the leading risk factor for throat cancer, says researcher

by Hisham Mehanna,The ConversationThe oropharynx is middle section of the throat (pharynx). Credit:Scientific Animations/Wikimedia Commons,CC BY-SAOver the past two decades, there ha

Updated on: January 30,2024

Oral sex is now the leading risk factor for throat cancer, says researcher

by Hisham Mehanna,The ConversationThe oropharynx is middle section of the throat (pharynx). Credit:Scientific Animations/Wikimedia Commons,CC BY-SAOver the past two decades, there ha

Updated on:January 30,2024

Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

byHelmholtz Association of German Research CentresMPS layout; red—media circuit with integrated pump; blue—pneumatic connectors; yellow—microwells for organoids; green—LUER-connectors). Credit:&

Updated on: January 07,2024

Exploring mini-labs as an alternative to animal testing for evaluating radiopharmaceuticals

byHelmholtz Association of German Research CentresMPS layout; red—media circuit with integrated pump; blue—pneumatic connectors; yellow—microwells for organoids; green—LUER-connectors). Credit:&

Updated on:January 07,2024

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,

Updated on: December 28,2023

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,

Updated on:December 28,2023

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on: January 10,2024

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on:January 10,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on: January 26,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on:January 26,2024

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul

Updated on: March 20,2024

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul

Updated on:March 20,2024